Axiomed Spine Corporation receives Ferchill Partner Award for its medical innovation

Oct 1 2009

At the 6^th Annual Cleveland Clinic Innovator Awards dinner, AxioMed Spine Corporation (www.axiomed.com) was awarded the Ferchill Partner Award for the company’s medical innovation and economic impact on the community. The Cleveland Clinic and AxioMed Spine Corporation collaborated on the development of the Freedom^® Lumbar Disc for the treatment of degenerative disc disease. The Freedom Lumbar Disc has been approved for commercial distribution in the European Union (EU) and is currently in a FDA approved pivotal Investigational Device Exemption study in key centers in the United States and EU.

Chris Coburn, Executive Director, of Cleveland Clinic Innovations, stated “We are pleased to be working with AxioMed Spine Corporation on the development of innovative spinal products like Freedom, with the hope of creating a new total disc to address degenerative disc disease. Through the Ferchill Partner Award, Cleveland Clinic Innovations recognizes their achievement in medical technology and impact on our community.”

Patrick A McBrayer, President and CEO of AxioMed Spine Corporation, went on to say, “Working with The Cleveland Clinic is a considerable asset to AxioMed. We benefit from their spine expertise and new product development experience. The surgeons with whom we collaborate have the knowledge, experience and creativity to continue to advance our formidable technology through the introduction of Freedom in Europe, continuation of our pivotal study as well as the acceleration of the development of our cervical device.”